Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Paweł K. Mazur(The University of Texas MD Anderson Cancer Center), Jens T. Siveke(German Cancer Research Center)
Cited by 414
Related Papers
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
|Nature|2014|407
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
|Cancer Discovery|2021|282
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
|Clinical Cancer Research|2022|145
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
|Nature Communications|2022|94
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
|Journal of Nuclear Medicine|2022|68